Vivos Therapeutics, Inc. announced a private placement for gross proceeds of $7.999533.7333 on January 5, 2023.The company will issue 2,000,000 common shares at issue price of $1.20, 4,666,667 pre-funded warrants at issue price of $1.1999, and common stock purchase warrants to purchase up to an aggregate of 6,666,667 shares of common stock. Each Common Stock Purchase Warrant entitles the holder, for a period of five years and 6 months, to purchase one share of Common Stock at an exercise price of $1.20 per share. Each Pre-Funded Warrant entitles the holder, for a period until all Pre-Funded Warrants are exercised, to purchase one share of Common Stock at an exercise price of $0.0001 per share.

The Private Placement is expected to close on January 9, 2023.